For the First Time, CMS Proposes Claims-Based Methods to Identify 340B Drugs Billed to Medicare Part D

CMS recently proposed two policies for identifying 340B claims billed to Medicare Part D.
In a first for the agency, the Centers for Medicare and Medicaid Services (CMS) is proposing to track 340B drugs [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Advocates Warn New CMS Proposed Rule Could Hurt 340B Program, Be ‘First Step Towards Payment Cuts’

Hospital groups and other 340B backers condemned proposals, which CMS included in its 900-plus page draft hospital outpatient prospective payment system and ambulatory surgical center rule released this week.
340B hospital advocates are raising concerns that a new Trump administration proposal to accelerate hospital outpatient payment cuts to offset [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

News Alert

CMS Proposes Accelerated OPPS Cuts to Offset 340B Remedy Payments and Medicare Drug Survey That Could Lead to Significant Part B Cuts

CMS has issued a draft 2026 Hospital Outpatient Prospective Payment System (OPPS) rule, which proposes accelerated cuts to offset 340B remedy payments. The agency also proposed a controversial Medicare drug survey.
The Trump administration this week proposed accelerating hospital outpatient payment cuts to offset previous 340B hospital lump sum repayments and [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Carter Introduces PBM Reform Bill That Includes 340B ‘Spread Pricing’ Reporting

U.S. Rep. Earl “Buddy” Carter (R-Ga.) unveiled the PBM Reform Act (H.R. 4317) on July 10.
U.S. Rep. Earl “Buddy” Carter (R-Ga.) recently led a bipartisan group of nearly a dozen U.S. House lawmakers in introducing [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Griffith, Harshbarger Officially Take Over as E&C Health Subcommittee’s GOP Leaders

U.S. Rep. Morgan Griffith (R-Va.) and U.S. Rep Diana Harshbarger (R-Tenn.) today officially took over as the E&C Health Subcommittee's chair and vice chair, respectively.
The U.S. House Committee that oversees federal 340B policy today enacted a series of personnel shakeups, including the new chair [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Drugmakers File New Appeal Briefs in Push to Overturn 340B Rebate Ruling

Drugmakers filed new briefs in their pending 340B rebate cases before the D.C. Circuit Court of Appeals
Four large drugmakers recently filed a pair of new briefs in their ongoing appeals of legal rulings that upheld the [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

In High-Stakes Meetings, 340B Stakeholders Push to Sway HHS’ Rebate Guidance Ahead of Release

More than a dozen stakeholder groups haver recently met with federal officials about HHS' highly-anticipated 340B rebate guidance.
In a flurry of meetings with federal officials, drug industry and provider groups are making a final push to influence [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Supreme Court Allows HHS Reorganization and Layoffs to Continue, Effect on 340B Oversight Unclear

The U.S. Supreme Court this week greenlit the Trump administration’s plans for massive layoffs and a reorganization at HHS—for now.
The U.S. Supreme Court this week greenlit the Trump administration’s plans for massive layoffs and a reorganization at the U.S. [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Griffith Named U.S. House E&C Committee’s Health Subcommittee Chair, 340B Critic Harshbarger Elevated to Vice Chair

U.S. Rep. Morgan Griffith (R-Va.) will take over as chairman of the House E&C Health Subcommittee, while U.S. Rep Diana Harshbarger (R-Tenn.) will become the panel’s new vice chair.
A Virginia Republican is set to replace longtime 340B critic U.S. Rep. Earl “Buddy” Carter (R-Ga.) as the chair of [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Five Drugmakers Exempt New States from 340B Contract Pharmacy Restrictions

AbbVie was among five drugmakers to announce new state exemptions to their 340B contract pharmacy restrictions in early July.
Five major drugmakers recently announced new contract pharmacy restriction exemptions for 340B covered entities located in South Dakota and other [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live